BOSTON, Dec. 20, 2016 -- Rapid7, Inc. (NASDAQ:RPD), a leading provider of IT and security analytics solutions, today announced that the Company has been designated as a Common Vulnerability and Exposures (CVE) Numbering Authority (CNA), effective immediately. Rapid7 will now be able to assign CVE numbers to vulnerabilities found in Rapid7’s and any other vendors’ products, whether they are disclosed by Rapid7 or third party researchers. CVEs assigned by Rapid7 will be added to the CVE list, an enumeration of information security vulnerabilities and exposures that provides a singular way of identifying publicly known cybersecurity issues.
The goal of CVE is to make it easier to share data across separate vulnerability tools, repositories, and services with standardized identifiers for given vulnerabilities or exposures. The common identifiers allow users to quickly and accurately access information about a problem across multiple information sources that are CVE-compatible. The MITRE Corporation (MITRE) manages and maintains the CVE List with assistance from the CVE Board. MITRE is a not-for-profit operator of seven federally funded research and development centers, and their mission is to work in the public interest. Their unique role allows them to provide an objective perspective with regard to disclosed vulnerabilities.
“We are honored to become a CNA and look forward to collaborating with MITRE, who have impressed us with their efforts to evolve the CVE program to meet ever-increasing needs,” said Corey Thomas, president and CEO at Rapid7. “Our support of reasonable disclosure practices is driven by our deep-seated commitment to supporting and empowering the community. Our goal is twofold: help improve and mature the security practices of vendors and manufacturers, while educating users on risk, so they can make informed decisions.”
Rapid7 has an established record of coordinated and reasonable disclosure practices, and has been a strong supporter of free and open security research through its open source efforts, including Metasploit Framework. As a provider of security software, services, and research, the Company takes security issues very seriously and recognizes the importance of privacy, security, and community outreach. In 2016 alone, Rapid7 coordinated with more than 25 vendors on vulnerability disclosures discovered by its researchers. These efforts are driven by a belief that security is a communal challenge and will only be meaningfully addressed through active collaboration. As such, the Company is committed to openly facilitating the sharing of security information that helps customers and the broader community learn, grow, and develop new security capabilities.
As a CNA, Rapid7 will assign CVE numbers to describe vulnerabilities identified in software products, once they are acknowledged by the affected vendors, in accordance with the rules and practices set forth by the CVE Board. More information about specific CVE guidelines can be found here: https://cve.mitre.org/cve/cna/CNA_Rules_v1.1.pdf.
For more information about Rapid7, please visit: https://www.rapid7.com/
About Rapid7
With Rapid7, technology professionals gain the clarity, command, and confidence to safely drive innovation and protect against risk. We make it simple to collect operational data across systems, eliminating blind spots and unlocking the information required to securely develop, operate, and manage today’s sophisticated applications and services. Our analytics and science transform your data into key insights so you can quickly predict, deter, detect, and remediate attacks and obstacles to productivity. Armed with Rapid7, technology professionals finally gain the insights needed to safely move their business forward. Rapid7 is trusted by more than 5,800 organizations across over 110 countries, including 37% of the Fortune 1000. To learn more about Rapid7 or get involved in our threat research, visit www.rapid7.com.
Press contact: Rachel E. Adam Rapid7, Senior PR Manager [email protected] (857) 415-4443


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Apple Turns 50: From Garage Startup to AI Crossroads
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



